Hypocalcemia Clinical Trial
Official title:
Determination of Parathyroid Function by Fluorescence With Indocyanine Green (ICG) After Total Thyroidectomy
The intensity of parathyroid fluorescence that occurs after intravenous injection of indocyanine green during the performance of a total thyroidectomy correlates with postoperative parathyroid function and could be used as a diagnostic marker of postoperative hypoparathyroidism and hypocalcemia.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | October 2020 |
Est. primary completion date | March 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients who are going to undergo total thyroidectomy, with or without cervical lymph node dissection. - Visualization of 2 or more parathyroid glands during the surgical act. - Normal renal and hepatic functions. - Absence of a history of hypersensitivity reactions to iodine or indocyanine green. - Able to understand the nature and protocol of the study and its procedures - Willingness to participate with the subsequent signing of informed consent. Exclusion Criteria: - Age <18 years - Hepatic or renal insufficiency - Hypersensitivity to iodine or to indocyanine green. - Pregnancy or lactation - Inability to understand the nature and procedures of the study. - Patients with known preoperative hyperparathyroidism. |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Universitari Son Espases | Palma De Mallorca | Illes Balears |
Lead Sponsor | Collaborator |
---|---|
Hospital Son Espases | Universitat de les Illes Balears |
Spain,
Bonnin-Pascual J, Álvarez-Segurado C, Jiménez-Segovia M, Bianchi A, Bonnin-Pascual F, Molina-Romero FX, González-Argente FX. Contributions of fluorescence to endocrine surgery. Cir Esp. 2018 Nov;96(9):529-536. doi: 10.1016/j.ciresp.2018.09.005. Epub 2018 — View Citation
Gálvez-Pastor S, Torregrosa NM, Ríos A, Febrero B, González-Costea R, García-López MA, Balsalobre MD, Pastor-Pérez P, Moreno P, Vázquez-Rojas JL, Rodríguez JM. Prediction of hypocalcemia after total thyroidectomy using indocyanine green angiography of parathyroid glands: A simple quantitative scoring system. Am J Surg. 2019 Jan 4. pii: S0002-9610(18)31264-9. doi: 10.1016/j.amjsurg.2018.12.074. [Epub ahead of print] — View Citation
Lang BH, Wong CK, Hung HT, Wong KP, Mak KL, Au KB. Indocyanine green fluorescence angiography for quantitative evaluation of in situ parathyroid gland perfusion and function after total thyroidectomy. Surgery. 2017 Jan;161(1):87-95. doi: 10.1016/j.surg.2016.03.037. Epub 2016 Nov 10. — View Citation
Rudin AV, McKenzie TJ, Thompson GB, Farley DR, Lyden ML. Evaluation of Parathyroid Glands with Indocyanine Green Fluorescence Angiography After Thyroidectomy. World J Surg. 2019 Jun;43(6):1538-1543. doi: 10.1007/s00268-019-04909-z. — View Citation
Vidal Fortuny J, Belfontali V, Sadowski SM, Karenovics W, Guigard S, Triponez F. Parathyroid gland angiography with indocyanine green fluorescence to predict parathyroid function after thyroid surgery. Br J Surg. 2016 Apr;103(5):537-43. doi: 10.1002/bjs.10101. Epub 2016 Feb 11. — View Citation
Vidal Fortuny J, Sadowski SM, Belfontali V, Guigard S, Poncet A, Ris F, Karenovics W, Triponez F. Randomized clinical trial of intraoperative parathyroid gland angiography with indocyanine green fluorescence predicting parathyroid function after thyroid surgery. Br J Surg. 2018 Mar;105(4):350-357. doi: 10.1002/bjs.10783. Epub 2018 Feb 6. — View Citation
Zaidi N, Bucak E, Yazici P, Soundararajan S, Okoh A, Yigitbas H, Dural C, Berber E. The feasibility of indocyanine green fluorescence imaging for identifying and assessing the perfusion of parathyroid glands during total thyroidectomy. J Surg Oncol. 2016 Jun;113(7):775-8. doi: 10.1002/jso.24237. Epub 2016 Apr 4. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Calcemia | Serum calcium level at 24 hours postoperatively | Day 1 after surgery | |
Primary | Subjective parathyroid fluorescence | Fluorescence intensity of the parathyroid glands after administration of indocyanine green (ICG), measured on a subjective analogue scale (0: no fluorescence, 1: hypofluorescence or heterogeneous fluorescence, 2: homogeneous hyperfluorescence). | Intraoperatively | |
Primary | Objective parathyroid fluorescence | Fluorescence intensity of the parathyroid glands after administration of indocyanine green (ICG), measured by specific computer software developed ad hoc. | Intraoperatively | |
Secondary | Age | Patient's age | Baseline | |
Secondary | Sex | Patient's gender | Baseline | |
Secondary | Body mass index | Patient's BMI | Baseline | |
Secondary | Surgery date | Day when surgery takes place | Baseline | |
Secondary | Preoperative diagnosis | Thyroid pathology indicating total thyroidectomy (thyroid carcinoma, atypical of uncertain significance, goiter or lymphocytic thyroiditis) | Baseline | |
Secondary | Vitamin D | Preoperative vitamin D level | Preoperative blood test | |
Secondary | PTH preop | Preoperative PTH level | Immediately before surgery | |
Secondary | PTH 10 min | PTH levels 10 minutes post-thyroidectomy | 10 minutes post-thyroidectomy | |
Secondary | Surgery | Scope of surgery: total thyroidectomy (TT), TT with central neck dissection, or TT with functional lateral neck dissection | Inmediately after surgery | |
Secondary | Time | Duration of surgery | Inmediately after surgery | |
Secondary | Parathyroid glands | Number of parathyroid glands located during surgery, | During surgery | |
Secondary | Parathyroid gland location | Location of the parathyroid glands (superior right, inf-right, sup-left, inf-left). | During surgery | |
Secondary | Pathologic result | Outcome of thyroid pathology (papillary carcinoma, nodular hyperplasia or lymphocytic thyroiditis) | during the first month after surgery | |
Secondary | Thyroid weight | Thyroid weight | during the first month after surgery | |
Secondary | PG in piece | Presence of parathyroid glands in the surgical piece and number | during the first month after surgery | |
Secondary | Stay | Number of days of postoperative hospital stay until the day of hospital discharge, measured as full days of 24 hours | During the first month after surgery | |
Secondary | Drain | Presence and number of surgical drainages | Inmediately after surgery | |
Secondary | PTH day 1 | PTH levels in the postoperative follow-up, | Day 1 after surgery | |
Secondary | Complications | Emergence of postoperative complications. | During the first month after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02892253 -
Parathyroid Autofluorescence Visualization in Thyroid Surgery: Impact on Postoperative Hypocalcemia
|
N/A | |
Completed |
NCT05043584 -
Near-infrared Autofluorescence (NIRAF)-Guided Total Thyroidectomy: Impact in Low-volume, Non-parathyroid Institutions
|
N/A | |
Recruiting |
NCT05885256 -
Clinical Assessment of Low Calcium In traUMa (CALCIUM)
|
||
Recruiting |
NCT04160637 -
Is There Benefit From Early Postoperative PTH Monitoring?
|
||
Completed |
NCT00506103 -
The No-Tie Technique Using the Harmonic Scalpel in Total Thyroidectomy With Central Neck Dissection: A Prospective Randomized Study
|
N/A | |
Recruiting |
NCT05585593 -
Registry for Hypoparathyroidism Wuerzburg
|
||
Recruiting |
NCT05586529 -
Effect of Preoperative High-dose Cholecalciferol in Prevention of Post-thyroidectomy Hypocalcaemia
|
N/A | |
Completed |
NCT01868750 -
Phase II Pre-operative Vitamin D Supplementation to Prevent Post-thyroidectomy Hypocalcemia
|
Phase 2 | |
Terminated |
NCT00623974 -
Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia
|
Phase 2 | |
Completed |
NCT00668200 -
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
|
Phase 4 | |
Completed |
NCT00630214 -
Prevention of Hypocalcemia in Patients Undergoing Total Thyroidectomy Plus Central Neck Dissection
|
Phase 2 | |
Not yet recruiting |
NCT03685877 -
Hypocalcemia in Infants and Children
|
||
Terminated |
NCT00001151 -
Studies With 1,25-Dihydroxycholecalciferol
|
Phase 2 | |
Completed |
NCT04750460 -
Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
|
Phase 3 | |
Not yet recruiting |
NCT03063060 -
The Impact of Vitamin D Deficiency on Hypocalcaemia Following Total Thyroidectomy
|
N/A | |
Not yet recruiting |
NCT04304573 -
Is Correcting Total Serum Calcium Levels Important After Thyroidectomy
|
||
Recruiting |
NCT05216419 -
Prevention of Postoperative Hypocalcemia of Oral Vitamin D Supplementation Before Total Thyroidectomy
|
Phase 4 | |
Recruiting |
NCT04775381 -
Total Post-thyroidectomy Hypocalcemia After Preoperative Cholecalciferol Supplementation
|
Phase 3 | |
Active, not recruiting |
NCT01632514 -
Vitamin D Deficiency and Postoperative Hypocalcemia
|
Phase 4 | |
Recruiting |
NCT05260255 -
Effect of Vitamin D Supplement on Disease Activity in SLE
|
N/A |